Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 52,702 shares at $88.88 ($4.7M) on 2024-02-16, disclosed to the SEC on 2024-02-16.
Scheduled sale ($4.7M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.88 | 26,351 | $2.3M | 50.0% |
| 2 | $88.88 | 26,351 | $2.3M | 50.0% |
| Total | $88.88 avg | 52,702 | $4.7M | 100% |
| Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |
| MRNA | SELL | 2023-06-16 | $20.4M | — | Filing → |